Am J Psychiatry

1. GALLUCCI J, Yu JC, Oliver LD, Nakua H, et al
   Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
   Am J Psychiatry. 2024;181:910-919.
   

   >> Share

   
   
2. REILLY TJ, McCutcheon RA
   Menopausal Hormone Therapy for Women With Schizophrenia: What's Stopping Us?
   Am J Psychiatry. 2024;181:854-855.
   

   >> Share

   
   
3. KRAMER EN, Velicu V
   Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain.
   Am J Psychiatry. 2024;181:935-936.
   

   >> Share

   
   
4. CHENGAPPA KNR, Cotes RO
   Clozapine's High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies-How Do We Get There?
   Am J Psychiatry. 2024;181:851-853.
   

   >> Share

   
   
5. MCINTYRE RS, Kwan ATH, Rosenblat JD, Teopiz KM, et al
   Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain: Response to Kramer and Velicu.
   Am J Psychiatry. 2024;181:936-937.
   

   >> Share

   
   
6. HWANG M, Brady R
   Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
   Am J Psychiatry. 2024;181:858-860.
   

   >> Share

   
   
7. ARNSTEN AFT, Datta D
   Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia.
   Am J Psychiatry. 2024;181:861-864.
   

   >> Share

   
   
8. TAMMINGA CA
   Psychosis Risk With Prescription Amphetamine.
   Am J Psychiatry. 2024;181:856-857.
   

   >> Share

   
   
9. KALIN NH
   Schizophrenia Spectrum Disorders and Psychosis.
   Am J Psychiatry. 2024;181:847-850.
   

   >> Share

   
   
10. LEUCHT S, Priller J, Davis JM
    Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application.
    Am J Psychiatry. 2024;181:865-878.
    

    >> Share

    
    
11. ARION D, Enwright JF 3rd, Gonzalez-Burgos G, Lewis DA, et al
    Cell Type-Specific Profiles and Developmental Trajectories of Transcriptomes in Primate Prefrontal Layer 3 Pyramidal Neurons: Implications for Schizophrenia.
    Am J Psychiatry. 2024;181:920-934.
    

    >> Share

    
    

    
    BMJ

12. TORJESEN I
    Schizophrenia: US approves first new treatment in decades.
    BMJ. 2024;386:q2133.
    

    >> Share

    
    

    
    J Clin Psychiatry

13. DE WINTER L, Jelsma A, Vermeulen JM, van Tricht M, et al
    Long-Term Changes in Cognition Among Patients With Schizophrenia Spectrum Disorders and Different Durations of Illness: A Meta-Analysis.
    J Clin Psychiatry. 2024;85:23r15134.
    

    >> Share

    
    

    
    Mol Psychiatry

14. KEANE BP, Abrham YT, Cole MW, Johnson BA, et al
    Functional dysconnectivity of visual and somatomotor networks yields a simple and robust biomarker for psychosis.
    Mol Psychiatry. 2024 Oct 4. doi: 10.1038/s41380-024-02767.
    

    >> Share

    
    

    
    PLoS Biol

15. YANG F, Zhu H, Cao X, Li H, et al
    Impaired motor-to-sensory transformation mediates auditory hallucinations.
    PLoS Biol. 2024;22:e3002836.
    

    >> Share

    
    

    
    Psychiatry Res

16. GIAMPETRUZZI E, Walker EF, Addington J, Bearden CE, et al
    Impact of adverse childhood experiences on risk for internalizing psychiatric disorders in youth at clinical high-risk for psychosis.
    Psychiatry Res. 2024;342:116214.
    

    >> Share

    
    
17. TEYMOURI K, Ebrahimi M, Chen CC, Sriretnakumar V, et al
    Sex-dependent association study of complement C4 gene with treatment-resistant schizophrenia and hospitalization frequency.
    Psychiatry Res. 2024;342:116202.
    

    >> Share

    
    

    
    Psychol Med

18. GOODING P, Harris K, Duxbury P, Pratt D, et al
    Influence of perceived harm due to substance use on the relationships between positive psychotic experiences and suicidal experiences in people with non-affective psychosis.
    Psychol Med. 2024 Oct 4:1-11. doi: 10.1017/S0033291724001764.
    

    >> Share

    
    
19. PANAYI P, Peters E, Bentall R, Hardy A, et al
    Complex PTSD symptoms predict positive symptoms of psychosis in the flow of daily life.
    Psychol Med. 2024 Oct 4:1-12. doi: 10.1017/S0033291724001934.
    

    >> Share

    
    

    
    Schizophr Res

20. COWAN HR
    Aligning phenomenology and neuroscience of the basic and narrative self in schizophrenia.
    Schizophr Res. 2024;274:245-246.
    

    >> Share

    
    
21. HAJDUK M, Park S, Pinkham AE
    Dyadic interaction in schizophrenia - A promising new avenue of investigation?
    Schizophr Res. 2024;274:243-244.
    

    >> Share

    
    
22. BJORNESTAD J, Tjora T, Joa I, Johannessen JO, et al
    Early and later remission from clinical high risk of psychosis. A latent class and predictor analysis.
    Schizophr Res. 2024;274:237-242.
    

    >> Share

    
    
23. JOHNSTONE S, Hubbard AN, Schenkel A, Ashare RL, et al
    Effects of acute smoking abstinence among people with schizophrenia: A systematic review and meta-analysis of laboratory studies.
    Schizophr Res. 2024;274:220-236.
    

    >> Share

    
    
24. WRIGHT AC, McKenna A, Tice JA, Rind DM, et al
    A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia.
    Schizophr Res. 2024;274:212-219.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share